MedPath

Skin Sparing Mastectomy and Immediate Breast Reconstruction With Latissimus Dorsi Flap After Neoadjuvant Chemotherapy and Radiotherapy (M-RIC)

Phase 2
Conditions
Breast Carcinoma
Registration Number
NCT01199354
Lead Sponsor
Clinique Clementville
Brief Summary

The aim of the study is to evaluate the feasibility and morbidity of skin sparing mastectomy and immediate breast reconstruction with latissimus dorsi flap after neoadjuvant chemotherapy and radiotherapy in invasive breast carcinoma.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • Women < 75 year old
  • Invasive breast carcinoma, indication for mastectomy
  • Women Health Organization (WHO) score of 0 and 1, primary chemotherapy, external radiotherapy performed less than 8 week earlier...
Exclusion Criteria
  • Women older than 75
  • Metastatic breast carcinoma
  • Antecedents of previously treated homolateral breast carcinoma
  • Documented cancer progression
  • Smoker at the moment of the indication surgery
  • Known diabetes, neoadjuvant hormonal treatment...

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Incidence of skin necrosis

To evaluate the incidence of skin necrosis in case of treatment with skin sparing mastectomy and immediate breas reconstruction with latissimus dorsi myocutaneous flap after neoadjuvant chemotherapy and radiotherapy.

Secondary Outcome Measures
NameTimeMethod
Rate of histological remission of the surgical specimen based on the anatomopathological examination

Trial Locations

Locations (9)

Polyclinique Urbain V

🇫🇷

Avignon, France

Centre Léon Bérard

🇫🇷

Lyon, France

Centre Jean Perrin

🇫🇷

Clermont-Ferrand, France

Clinique Belledonne

🇫🇷

Saint Martin d'Hères, France

Groupe Hospitalier Mutualiste Clinique les Eaux Claires

🇫🇷

Grenoble, France

Clinique Clementville

🇫🇷

Montpellier, France

Institut Paoli Calmettes

🇫🇷

Marseille, France

Institut Claudius Regaud

🇫🇷

Toulouse, France

CRLCC Val d'Aurelle

🇫🇷

Montpellier, France

© Copyright 2025. All Rights Reserved by MedPath